
ABVC BioPharma Announces Spin-Off of BioKey Subsidiary via Dividend Distribution to Shareholders
ABVC BioPharma plans to spin off its subsidiary BioKey (Cayman), Inc. by distributing 15% of BioKey shares as a dividend to ABVC shareholders, aiming to unlock subsidiary value and provide direct participation in BioKey's growth.
Read full story


























